当前位置： SCI文献检索 > CLINICAL THERAPEUTICS期刊下所有文献 > In vitro susceptibility of Streptococcus bovis to six antibiotics.

In vitro susceptibility of Streptococcus bovis to six antibiotics.

Abstract：

:A recent report of two isolates of Streptococcus bovis resistant to killing by low levels of penicillin G prompted this study of the in vitro susceptibility of 100 clinical isolates of S bovis to six antibiotics. Using a microdilution method, we found the minimum bactericidal concentrations for 99% of the isolates to be as follows: penicillin G, 0.5 microgram/ml; methicillin, 16 micrograms/ml; ampicillin, 0.5 microgram/ml; cephalothin, 2 micrograms/ml; clindamycin, 2 micrograms/ml; and vancomycin, 2 micrograms/ml. The high-level resistance of S bovis to penicillin G previously described was not seen. This study suggests that penicillin G can still prove effective in treating most infections caused by S bovis, including infective endocarditis, and that cephalothin and vancomycin are useful alternative agents.

journal_name

Clin Ther

journal_title

Clinical therapeutics

authors

Klein RS,Milazzo JJ,Edberg SC

subject

Has Abstract

pub_date

1984-01-01 00:00:00

pages

518-23

issue

4

eissn

0149-2918

issn

1879-114X

journal_volume

6

pub_type

杂志文章

相关文献

CLINICAL THERAPEUTICS文献大全
  • Medicare Part D research highlights and policy updates, 2013: impact and insights.

    abstract：BACKGROUND:Since its implementation in 2006, Medicare Part D has evolved from a program that offered basic access to covered drugs for beneficiaries to one that has the potential to affect patient outcomes. OBJECTIVES:The purpose of this article was to highlight key research findings on Medicare Part D published in 20...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2013.02.024

    authors： Stubbings J,Lau DT

    更新日期：2013-04-01 00:00:00

  • A review of combination therapy in patients with benign prostatic hyperplasia.

    abstract：BACKGROUND:Trials of monotherapy with alpha(1)-adrenergic-receptor antagonists (alpha(1)ARAs) and 5 alpha-reductase inhibitors (5ARIs) have found that the former drug class is effective in managing benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms (LUTS) and improving the maximal urinary flow rate...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0149-2918(07)80077-4

    authors： McVary KT

    更新日期：2007-03-01 00:00:00

  • Amino acids for dialysis patients.

    abstract：:Calorie/protein malnutrition is a common problem among dialysis patients. A study was designed to determine the value of adding a mixture of amino acids to the diet of 36 patients (mean age, 42 years) who had been receiving triweekly hemodialysis for periods ranging from 1 to 13 years. For 1 month the patients receive...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Mastroiacovo P,Pace V,Sagliaschi G

    更新日期：1993-07-01 00:00:00

  • Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study.

    abstract：BACKGROUND:Alendronate, an oral bisphosphonate, is available for the treatment of osteoporosis in a 70-mg once-weekly and a 10-mg once-daily formulation. OBJECTIVES:This study aimed to determine patient preference for once-weekly versus once-daily dosing with alendronate, and to determine which treatment regimen the p...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：10.1016/s0149-2918(02)80085-6

    authors： Simon JA,Lewiecki EM,Smith ME,Petruschke RA,Wang L,Palmisano JJ

    更新日期：2002-11-01 00:00:00

  • Anxiolytic efficacy and safety of ketazolam compared with diazepam and placebo.

    abstract：:A 28-day, double-blind study involving 56 outpatients ws initiated to compare the anxiolytic efficacy and safety of ketazolam once a day at bedtime (HS) with diazepam given three times a day (TID) and placebo HS or TID. Ketazolam HS was at least equivalent, and in some respects superior, to diazepam TID with fewer, le...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章

    doi：

    authors： Kim KK,Sirman A,Trainor FS,Lee BY

    更新日期：1980-01-01 00:00:00

  • Comparison of actual and stated concentrations of pharmaceuticals manufactured in Mexico.

    abstract：BACKGROUND:During the past 5 years, there has been much concern about the safety of and ease of access to drugs that are unavailable without a prescription in the United States but are manufactured and can be purchased over the counter (OTC) in Mexico. However, based on a literature search, studies have not been perfor...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2005.05.007

    authors： Schwertner HA,Storrow AB

    更新日期：2005-05-01 00:00:00

  • Pegylated interferons for the treatment of chronic hepatitis C infection.

    abstract：BACKGROUND:Interferon (IFN) alfa is a clinically effective therapy used in a wide range of viral infections and cell-proliferative disorders. Combination therapy with IFN alfa-2b and ribavirin is the current standard of care for the treatment of chronic hepatitis C (CHC) infection. However, standard IFN alfa has the dr...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0149-2918(02)80042-x

    authors： Luxon BA,Grace M,Brassard D,Bordens R

    更新日期：2002-09-01 00:00:00

  • Cost of Bleeding-related Episodes in Adult Patients With Primary Immune Thrombocytopenia: A Population-based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States.

    abstract：PURPOSE:We estimated the real-world costs of bleeding-related episodes (BREs) in adults with primary immune thrombocytopenia (ITP). METHODS:This retrospective cohort study used the MarketScan Commercial Claims and Encounters and Medicare Supplemental and Coordination of Benefits databases. We identified adult patients...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2017.01.023

    authors： Lin J,Zhang X,Li X,Chandler D,Altomare I,Wasser JS,Cetin K

    更新日期：2017-03-01 00:00:00

  • Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review.

    abstract：PURPOSE:This article outlines several important issues regarding the management of patients with gout. The topics discussed include best practices for gout based on the most current guidelines, opportunities for improving gout management, and current and emerging therapies for gout. METHODS:[PubMed and Google Scholar ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2016.12.011

    authors： Keenan RT

    更新日期：2017-02-01 00:00:00

  • Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks.

    abstract：BACKGROUND:Short-term studies have demonstrated a modest weight-reducing to weight-neutral effect among patients receiving bupropion sustained-release (SR) for the treatment of depression. OBJECTIVE:This study was conducted to evaluate the long-term effects of bupropion SR on body weight in patients with depression. ...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/s0149-2918(02)85141-4

    authors： Croft H,Houser TL,Jamerson BD,Leadbetter R,Bolden-Watson C,Donahue R,Metz A

    更新日期：2002-04-01 00:00:00

  • Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series.

    abstract：BACKGROUND:Antimicrobial prophylaxis in select neutropenic patients has reduced fever, infection rates, hospital length of stay, and hospitalization rates. Guidelines from the Infectious Diseases Society of America recommend the consideration of prophylaxis with a fluoroquinolone in patients at high risk for infection ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2014.04.013

    authors： Wojenski DJ,Barreto JN,Wolf RC,Tosh PK

    更新日期：2014-06-01 00:00:00

  • Inhibition of leukotriene synthesis, pharmacokinetics, and tolerability of a novel dietary fatty acid formulation in healthy adult subjects.

    abstract：BACKGROUND:Numerous studies have explored dietary-management strategies for decreasing leukotriene synthesis by inflammatory cells through supplementation with polyunsaturated fatty acids such as gamma-linolenic acid (GLA) and eicosapentaenoic acid (EPA). OBJECTIVES:This study sought to determine the optimal daily int...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/s0149-2918(03)80116-9

    authors： Surette ME,Koumenis IL,Edens MB,Tramposch KM,Chilton FH

    更新日期：2003-03-01 00:00:00

  • Vitamin D Provides Benefit Based on the Proinflammatory Effects of Homocysteine in Elderly Patients With Type 2 Diabetes Mellitus.

    abstract：PURPOSE:It is unclear whether vitamin D provides any benefit against the pro-inflammatory effects of homocysteine in elderly patients with type 2 diabetes mellitus (T2DM). METHODS:We compared lymphocyte counts for CD3, CD19, CD4, and CD8 subsets between elderly (age ≥65 years) T2DM patients (n = 5098) and nondiabetes ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2020.08.009

    authors： Ma C,Zhao Y,Liu Z

    更新日期：2020-10-01 00:00:00

  • Potential drug-drug interaction between interferon alfa-2b and gemfibrozil in a patient with malignant melanoma.

    abstract：BACKGROUND:In the United States, patients with high-risk stage II or III melanoma are often treated with adjuvant interferon (IFN) therapy for 1 year after surgery. Adverse events associated with IFN alfa-2b use are primarily constitutional symptoms. However, hypertriglyceridemia requiring treatment has been reported. ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2005.12.002

    authors： Wong SF,Jakowatz JG,Taheri R

    更新日期：2005-12-01 00:00:00

  • Relative Bioavailability of Methylphenidate Extended-release Chewable Tablets Chewed Versus Swallowed Whole.

    abstract：PURPOSE:Methylphenidate hydrochloride extended-release chewable tablet (MPH ERCT) is approved for treatment of attention deficit hyperactivity disorder in patients aged 6 years and older. This article evaluates the pharmacokinetic parameters and relative bioavailability of MPH ERCT when chewed versus swallowed whole. ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2018.03.016

    authors： Abbas R,Childress AC,Nagraj P,Rolke R,Berry SA,Palumbo DR

    更新日期：2018-05-01 00:00:00

  • Gangrenous and perforated appendicitis with peritonitis: treatment and bacteriology.

    abstract：:A comparison of single-agent antimicrobial therapy in the treatment of patients with perforated or gangrenous appendicitis and peritonitis was performed in a double-blind, randomized, prospective trial. Pathologic documentation of advanced appendicitis and positive intraoperative specimen cultures were required for in...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：

    authors： Bennion RS,Thompson JE,Baron EJ,Finegold SM

    更新日期：1990-01-01 00:00:00

  • A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.

    abstract：BACKGROUND:Valproic acid has been associated with a highly variable intersubject absorptive phase; therefore, magnesium salt (magnesium valproate [MgV]) was developed to diminish variation during enteric absorption. OBJECTIVES:The aims of this study were to assess the pharmacokinetics of single oral doses of MgV 500-m...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.clinthera.2009.09.016

    authors： Marcelín-Jiménez G,Angeles-Moreno AP,Contreras-Zavala L,Morales-Martínez M,Rivera-Espinosa L

    更新日期：2009-09-01 00:00:00

  • Enoxacin in the treatment of typhoid fever.

    abstract：:Enoxacin 400 mg twice daily was given orally to 40 patients who had Salmonella typhi- or Salmonella paratyphi-positive blood or bone marrow cultures. One patient was switched to parenteral therapy within 48 hours of study enrollment, but the remaining 39 patients were given enoxacin for 10 to 14 days. All 39 patients ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Ahmed A,Salahuddin N,Ahsan T,Afsar S,Nasir N,Farooqui S,Chaoudri AN,Akhtar MA,Agha I,Nagi N

    更新日期：1992-11-01 00:00:00

  • Pharmacokinetic evaluation of cimetidine in newborn infants.

    abstract：:The pharmacokinetics of cimetidine were studied in three newborn infants with reflux esophagitis or stress ulcer. One infant was given 5 mg/kg intravenously (IV), one was given 10 mg/kg IV, and one was given 10 mg orally. Serum concentrations 30 minutes after administration were 1.2 micrograms/ml, 5 micrograms/ml, and...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Stile IL,Simon R,Hiatt IM,Hegyi T

    更新日期：1985-01-01 00:00:00

  • Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propiona

    abstract：BACKGROUND:The use of dry-powder inhalers (DPIs) to administer respiratory medicines is increasing, and new DPIs are likely to be developed because of expiring patents. However, there is considerable debate concerning the extent to which DPIs are interchangeable without altering disease control or the safety profile of...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2009.02.007

    authors： Daley-Yates PT,Parkins DA,Thomas MJ,Gillett B,House KW,Ortega HG

    更新日期：2009-02-01 00:00:00

  • Bioavailability of three rufinamide oral suspensions compared with the marketed 400-mg tablet formulation: results from a randomized-sequence, open-label, four-period, four-sequence crossover study in healthy subjects.

    abstract：BACKGROUND:Rufinamide is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients aged ≥4 years. OBJECTIVES:The primary purpose of this study was to compare the relative bioavailability and other pharmacokinetics of rufinamide administered as a 400-mg tablet formulation (r...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.clinthera.2011.01.016

    authors： Critchley DJ,Aluri J,Boyd P,Whayman M,Narurkar M,Delargy H,Bibbiani F

    更新日期：2011-01-01 00:00:00

  • Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.

    abstract：OBJECTIVE:This post hoc analysis was aimed to summarize the efficacy and tolerability of duloxetine as represented by number needed to treat (NNT) and number needed to harm (NNH) to provide a clinically useful assessment of the position of duloxetine among current agents used to treat diabetic peripheral neuropathic pa...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1016/j.clinthera.2007.12.002

    authors： Kajdasz DK,Iyengar S,Desaiah D,Backonja MM,Farrar JT,Fishbain DA,Jensen TS,Rowbotham MC,Sang CN,Ziegler D,McQuay HJ

    更新日期：2007-01-01 00:00:00

  • Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: a 12-week study.

    abstract：:Etodolac, aspirin, and placebo were evaluated for efficacy and safety in 18 patients with adult-onset, active rheumatoid arthritis. This was a 12-week, double-blind, parallel-group study divided into drug titration and maintenance periods and preceded by a washout period of up to two weeks. The mean daily maintenance ...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章

    doi：

    authors： Edwards W

    更新日期：1983-01-01 00:00:00

  • Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas.

    abstract：:Antihypertensive drugs are commonly prescribed for the treatment of patients with both diabetes and hypertension. However, the role of selected agents in the development of hypoglycemia remains controversial. The main objective of this study was to evaluate the effect of antihypertensive agents on the risk of hypoglyc...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/s0149-2918(99)80039-3

    authors： Thamer M,Ray NF,Taylor T

    更新日期：1999-08-01 00:00:00

  • Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infants.

    abstract：BACKGROUND:Respiratory syncytial virus (RSV) lower respiratory tract infection (LRI) in early life has been associated with sustained airway hyperreactivity during childhood; however, corresponding data in premature infants are sparse. OBJECTIVE:The objective of this study was to determine whether RSV-LRI during early...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2011.01.007

    authors： Romero JR,Stewart DL,Buysman EK,Fernandes AW,Jafri HS,Mahadevia PJ

    更新日期：2010-12-01 00:00:00

  • Glycopyrrolate for chronic drooling in children.

    abstract：BACKGROUND:Sialorrhea, or drooling, is seen in the pediatric population, especially in patients with cerebral palsy and other neurodevelopmental disabilities. If medication use is warranted, anticholinergic agents are the drug of choice; however, adverse effects limit their use. Glycopyrrolate, a synthetic anticholiner...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2012.02.026

    authors： Eiland LS

    更新日期：2012-04-01 00:00:00

  • Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.

    abstract：BACKGROUND:Patients with grade 2 or 3 hypertension may require high-dose combination therapy to achieve blood pressure (BP) targets in a timely manner. OBJECTIVES:This study compared the effectiveness and tolerability of a single-pill combination (SPC) of telmisartan/hydrochlorothiazide 80/25 mg (T80/H25) with T80 mon...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1016/j.clinthera.2012.05.007

    authors： Zhu DL,Bays H,Gao P,Mattheus M,Voelker B,Ruilope LM

    更新日期：2012-07-01 00:00:00

  • Radiotherapy during pregnancy: effects on fetuses and neonates.

    abstract：:To optimize the efficacy of radiotherapy for cancer patients who are pregnant, the following factors must be considered: the potential effects of the therapy on fetuses and neonates, the stage and prognosis of the mother's disease, and the possible risks to the patient of restricting cancer treatment. Malformations an...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/s0149-2918(97)80101-4

    authors： Nakagawa K,Aoki Y,Kusama T,Ban N,Nakagawa S,Sasaki Y

    更新日期：1997-07-01 00:00:00

  • Short-term Safety, Tolerability, and Pharmacokinetics of MRX-I, an Oxazolidinone Antibacterial Agent, in Healthy Chinese Subjects.

    abstract：PURPOSE:This study was designed to evaluate the safety and pharmacokinetic profiles of MRX-I tablet, an oxazolidinone antibacterial agent, in healthy Chinese subjects. METHODS:The study was composed of 3 sequential periods. Period 1 was a randomized, double-blind, placebo-controlled, sequential ascending dose (50 to 1...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.clinthera.2017.12.017

    authors： Wu X,Li Y,Zhang J,Zhang Y,Yu J,Cao G,Chen Y,Guo B,Shi Y,Huang J,Cao Y,Liu X,Wu J,Gordeev MF,Yuan H,Wang W

    更新日期：2018-02-01 00:00:00

  • Update on disease-modifying treatments for multiple sclerosis.

    abstract：PURPOSE:The purpose of this review is to discuss the selection and use of disease- modifying treatments for patients with relapsing forms of multiple sclerosis (MS). METHODS:PubMed was searched (1966-2014) using the terms multiple sclerosis, treatment, interferon, glatiramer acetate, dimethyl fumarate, fingolimod, ter...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2014.08.006

    authors： Carrithers MD

    更新日期：2014-12-01 00:00:00